Showing 1 - 5 results of 5 for search 'Hamid Emamekhoo', query time: 0.03s Refine Results
  1. 1
    PARP inhibitors in metastatic prostate cancer

    PARP inhibitors in metastatic prostate cancer by Amy K. Taylor, David Kosoff, David Kosoff, Hamid Emamekhoo, Hamid Emamekhoo, Joshua M. Lang, Joshua M. Lang, Christos E. Kyriakopoulos, Christos E. Kyriakopoulos

    Published 2023-04-01
    Get full text
    Article
  2. 2
    Phase 2 trial of a DNA vaccine (pTVG-HP) and nivolumab in patients with castration-sensitive non-metastatic (M0) prostate cancer

    Phase 2 trial of a DNA vaccine (pTVG-HP) and nivolumab in patients with castration-sensitive non-metastatic (M0) prostate cancer by Douglas G McNeel, Glenn Liu, Ellen Wargowski, Hamid Emamekhoo, Jens C Eickhoff, Laura E Johnson, Christos E Kyriakopoulos, Tommaso P Tonelli

    Published 2023-12-01
    Get full text
    Article
  3. 3
    Phase 2 trial of T-cell activation using MVI-816 and pembrolizumab in patients with metastatic, castration-resistant prostate cancer (mCRPC)

    Phase 2 trial of T-cell activation using MVI-816 and pembrolizumab in patients with metastatic, castration-resistant prostate cancer (mCRPC) by Douglas G McNeel, Glenn Liu, Joshua M Lang, Ellen Wargowski, Hamid Emamekhoo, Mary Jane Brennan, Jens C Eickhoff, Laura E Johnson, Christos E Kyriakopoulos

    Published 2022-03-01
    Get full text
    Article
  4. 4
    Concurrent durvalumab and radiation therapy (DUART) followed by adjuvant durvalumab in patients with localized urothelial cancer of bladder: results from phase II study, BTCRC-GU15-023

    Concurrent durvalumab and radiation therapy (DUART) followed by adjuvant durvalumab in patients with localized urothelial cancer of bladder: results from phase II study, BTCRC-GU15... by Hong Zheng, Junjia Zhu, Monika Joshi, Mark Stein, Alexander Sankin, Deepak Kilari, Yousef Zakharia, Joseph Drabick, Ralph Hauke, Hamid Emamekhoo, Todd Schell, Leonard Tuanquin, Vonn Walter, Matthew Kaag, Jiangang Liao, Sheldon L Holder, Suzzane Merrill, Joshua Warrick, Benjamin Gartrel, David J Degraff

    Published 2023-02-01
    Get full text
    Article
  5. 5
    A clinical-grade liquid biomarker detects neuroendocrine differentiation in prostate cancer

    A clinical-grade liquid biomarker detects neuroendocrine differentiation in prostate cancer by Shuang G. Zhao, Jamie M. Sperger, Jennifer L. Schehr, Rana R. McKay, Hamid Emamekhoo, Anupama Singh, Zachery D. Schultz, Rory M. Bade, Charlotte N. Stahlfeld, Cole S. Gilsdorf, Camila I. Hernandez, Serena K. Wolfe, Richel D. Mayberry, Hannah M. Krause, Matt Bootsma, Kyle T. Helzer, Nicholas Rydzewski, Hamza Bakhtiar, Yue Shi, Grace Blitzer, Christos E. Kyriakopoulos, David Kosoff, Xiao X. Wei, John Floberg, Nan Sethakorn, Marina Sharifi, Paul M. Harari, Wei Huang, Himisha Beltran, Toni K. Choueiri, Howard I. Scher, Dana E. Rathkopf, Susan Halabi, Andrew J. Armstrong, David J. Beebe, Menggang Yu, Kaitlin E. Sundling, Mary-Ellen Taplin, Joshua M. Lang

    Published 2022-11-01
    Get full text
    Article

Search Tools: